| CGCG clinical practice guidelines for the management of adult diffuse gliomas T Jiang, Y Mao, W Ma, Q Mao, Y You, X Yang, C Jiang, C Kang, X Li, ... Cancer letters 375 (2), 263-273, 2016 | 440 | 2016 |
| Long Noncoding RNA NEAT1, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/β-Catenin Pathway by Scaffolding … Q Chen, J Cai, Q Wang, Y Wang, M Liu, J Yang, J Zhou, C Kang, M Li, ... Clinical Cancer Research 24 (3), 684-695, 2018 | 312 | 2018 |
| Clinical practice guidelines for the management of adult diffuse gliomas T Jiang, DH Nam, Z Ram, W Poon, J Wang, D Boldbaatar, Y Mao, W Ma, ... Cancer letters 499, 60-72, 2021 | 289 | 2021 |
| Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis C Zha, X Meng, L Li, S Mi, D Qian, Z Li, P Wu, S Hu, S Zhao, J Cai, Y Liu Cancer Biology & Medicine 17 (1), 154, 2020 | 189 | 2020 |
| Bioinformatic profiling identifies an immune-related risk signature for glioblastoma W Cheng, X Ren, C Zhang, J Cai, Y Liu, S Han, A Wu Neurology 86 (24), 2226-2234, 2016 | 183 | 2016 |
| Lnc-TALC promotes O6-methylguanine-DNA methyltransferase expression via regulating the c-Met pathway by competitively binding with miR-20b-3p P Wu, J Cai, Q Chen, B Han, X Meng, Y Li, Z Li, R Wang, L Lin, C Duan, ... Nature communications 10 (1), 2045, 2019 | 164 | 2019 |
| Nanocomposites inhibit the formation, mitigate the neurotoxicity, and facilitate the removal of β-amyloid aggregates in Alzheimer’s disease mice Y Zhao, J Cai, Z Liu, Y Li, C Zheng, Y Zheng, Q Chen, H Chen, F Ma, Y An, ... Nano letters 19 (2), 674-683, 2018 | 142 | 2018 |
| Molecular and clinical characterization of TIM-3 in glioma through 1,024 samples G Li, Z Wang, C Zhang, X Liu, J Cai, Z Wang, H Hu, F Wu, Z Bao, Y Liu, ... Oncoimmunology 6 (8), e1328339, 2017 | 128 | 2017 |
| Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways X Meng, Y Zhao, B Han, C Zha, Y Zhang, Z Li, P Wu, T Qi, C Jiang, Y Liu, ... Nature communications 11 (1), 594, 2020 | 120 | 2020 |
| Classification based on mutations of TERT promoter and IDH characterizes subtypes in grade II/III gliomas P Yang, J Cai, W Yan, W Zhang, Y Wang, B Chen, G Li, S Li, C Wu, K Yao, ... Neuro-oncology 18 (8), 1099-1108, 2016 | 116 | 2016 |
| Glioblastoma cell–derived lncRNA-containing exosomes induce microglia to produce complement C5, promoting chemotherapy resistance Z Li, X Meng, P Wu, C Zha, B Han, L Li, N Sun, T Qi, J Qin, Y Zhang, ... Cancer Immunology Research 9 (12), 1383-1399, 2021 | 115 | 2021 |
| Immunogenomic analysis reveals LGALS1 contributes to the immune heterogeneity and immunosuppression in glioma Q Chen, B Han, X Meng, C Duan, C Yang, Z Wu, D Magafurov, S Zhao, ... International journal of cancer 145 (2), 517-530, 2019 | 100 | 2019 |
| A compound AC1Q3QWB selectively disrupts HOTAIR-mediated recruitment of PRC2 and enhances cancer therapy of DZNep Y Li, Y Ren, Y Wang, Y Tan, Q Wang, J Cai, J Zhou, C Yang, K Zhao, K Yi, ... Theranostics 9 (16), 4608, 2019 | 92 | 2019 |
| Targeting the SMO oncogene by miR-326 inhibits glioma biological behaviors and stemness W Du, X Liu, L Chen, Z Dou, X Lei, L Chang, J Cai, Y Cui, D Yang, Y Sun, ... Neuro-oncology 17 (2), 243-253, 2015 | 92 | 2015 |
| Applications of brain organoids in neurodevelopment and neurological diseases N Sun, X Meng, Y Liu, D Song, C Jiang, J Cai Journal of Biomedical Science 28 (1), 30, 2021 | 90 | 2021 |
| ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma B Han, X Meng, P Wu, Z Li, S Li, Y Zhang, C Zha, Q Ye, C Jiang, J Cai, ... Theranostics 10 (7), 3351, 2020 | 86 | 2020 |
| ATRX mRNA expression combined with IDH1/2 mutational status and Ki-67 expression refines the molecular classification of astrocytic tumors: evidence from the whole … J Cai, P Yang, C Zhang, W Zhang, Y Liu, Z Bao, X Liu, W Du, H Wang, ... Oncotarget 5 (9), 2551, 2014 | 85 | 2014 |
| DNA damage repair alterations modulate M2 polarization of microglia to remodel the tumor microenvironment via the p53-mediated MDK expression in glioma X Meng, C Duan, H Pang, Q Chen, B Han, C Zha, M Dinislam, P Wu, Z Li, ... EBioMedicine 41, 185-199, 2019 | 81 | 2019 |
| Recent advances in targeted therapy for glioma. JC Lin L, Cai J Curr Med Chem, 2016 | 81* | 2016 |
| Upregulation of miR-181s reverses mesenchymal transition by targeting KPNA4 in glioblastoma H Wang, T Tao, W Yan, Y Feng, Y Wang, J Cai, Y You, T Jiang, C Jiang Scientific reports 5 (1), 13072, 2015 | 80 | 2015 |
Pengfei Wu中国科学技术大学附属第一医院Adresse e-mail validée de ustc.edu.cn